Quantcast

Yet Another ‘Highly Effective’ Vaccine

A volunteer receives an injection in Johannesburg, as part of Africa’s first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. AstraZeneca says late-stage trials of its COVID-19 vaccine were “highly effective” in preventing disease. (Siphiwe Sibeko/Pool via AP)

“AstraZeneca said it will immediately apply for early approval of the vaccine where possible, and it will seek an emergency use listing from the World Health Organization.”

Third major drug company reports COVID-19 vaccine with 90% or better effectiveness

Nov 23, 2020

LONDON (AP) — AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is easier to distribute than some of its rivals.

The results are based on interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca. No hospitalizations or severe cases of COVID-19 were reported in those receiving the vaccine.

...article continued below
- Advertisement -

“These findings show that we have an effective vaccine that will save many lives,” Oxford University Professor Andrew Pollard, chief investigator for the trial, said in a statement. “Excitingly, we’ve found that one of our dosing regimens may be around 90% effective.”

AstraZeneca is the third major drug company to report late-stage results for its potential COVID-19 vaccine as the world anxiously waits for vaccines that will end the pandemic that has killed almost 1.4 million people. Pfizer and Moderna last week reported preliminary results from late-stage trials showing their vaccines were almost 95% effective.

Unlike the Pfizer and Moderna vaccines, the Oxford-AstraZeneca candidate doesn’t have to be stored at ultra-cold temperatures, making it easier to distribute, especially in developing countries. All three vaccines must be approved by regulators before they can be widely distributed.

“The Oxford vaccine can be stored in the fridge, as opposed to the freezer like the other two vaccines, which means it is a more practical solution for use worldwide,” said Peter Horby, professor of Emerging Infectious Diseases and Global Health at Oxford.

The results come as a second wave of COVID-19 hits many countries, once again shutting businesses, restricting social interaction and pummeling the world economy.

...article continued below
- Advertisement -

AstraZeneca said it will immediately apply for early approval of the vaccine where possible, and it will seek an emergency use listing from the World Health Organization, so it can make the vaccine available in low-income countries.

The AstraZeneca trial looked at two different dosing regimens. A half-dose of the vaccine followed by a full dose at least one month later was 90% effective. Another approach, giving patients two full doses one month apart, was 62% effective. The combined results showed an average efficacy rate of 70%.

The vaccine uses a weakened version of a common cold virus that is combined with genetic material for the characteristic spike protein of the virus that causes COVID-19. After vaccination, the spike protein primes the immune system to attack the virus if it later infects the body.

The vaccine can be transported under “normal refrigerated conditions” of 2-8 degrees Celsius (36-46 degrees Fahrenheit), AstraZeneca said. By comparison, Pfizer plans to distribute its vaccine using specially designed “thermal shippers” that use dry ice to maintain temperatures of minus-70 degrees Celsius (minus-94 degrees Fahrenheit).

Peter Openshaw, professor of experimental medicine at Imperial College London, said the finding that a smaller initial dose is more effective than a larger one is good news because it may reduce costs and mean more people can be vaccinated.

“The report that an initial half-dose is better than a full dose seems counterintuitive for those of us thinking of vaccines as normal drugs: With drugs, we expect that higher doses have bigger effects, and more side-effects,” he said. “But the immune system does not work like that.”

The results reported Monday come from trials in the U.K. and Brazil that involved 23,000 people. Late-stage trials are also underway in the U.S., Japan, Russia, South Africa, Kenya and Latin America, with further trials planned for other European and Asian countries.

AstraZeneca has been ramping up manufacturing capacity, so it can supply hundreds of millions of doses of the vaccine starting in January, Chief Executive Pascal Soriot said earlier this month.

Soriot said Monday that the Oxford vaccine’s simpler supply chain and AstraZeneca’s commitment to provide it on a nonprofit basis during the pandemic mean it will be affordable and available to people around the world.

“This vaccine’s efficacy and safety confirm that it will be highly effective against COVID-19 and will have an immediate impact on this public health emergency,” Soriot said.
British Health Secretary Matt Hancock said he felt “a great sense of relief” at the news from AstraZeneca.

Britain has ordered 100 million doses of the Oxford vaccine, and the government says several million doses can be produced before the end of the year if it is approved by regulators.

Just months ago, “the idea that by November we would have three vaccines, all of which have got high effectiveness … I would have given my eye teeth for,” Hancock said.

RECENTLY ON HEADLINE HEALTH: 

Facebook Bans Anti-Vax Group

New Vax Is 94.5% Effective, Says Moderna

Doctor Slams Cuomo Over Anti-Vax Remarks

ALSO ON HEADLINE HEALTH TODAY: Millions IGNORE Fauci | “Disgusted By Your Politicization Of This Epidemic” | FSU Ripped For Postponing Clemson Game

- Advertisement -
- Advertisement -

TRENDING

Current Vaccines Projected To Fail

London (CNN) An analysis by British academics, published Friday by the UK Government's official scientific advisory group, says that they believe it is "almost...

Democrat’s Wish For Lindsey Graham: “Hope He Dies”

Fox News – Kate Coyne-McCoy, the chief strategist of the Rhode Island Democratic Party, faced swift criticism late Monday over a tweet about Sen....

Deja Vu All Over Again: Wuhan’s Huge Covid Outbreak

China Orders Mass Testing In Wuhan As COVID Outbreak Spreads BEIJING (AP) — China suspended flights and trains, canceled professional basketball league games and announced...

Florida, Texas Are Covid Epicenters

TUESDAY, AUG 3 2021 Florida And Texas Are Covid Epicenters With Third Of US Cases Reported There In Florida, criticism grows over Republican Gov. Ron DeSantis'...

Vaccine 99.999% Effective Against Deadly Covid-19 Breakthroughs

(CNN)More than 99.99% of people fully vaccinated against Covid-19 have not had a breakthrough case resulting in hospitalization or death, according to the latest...

Hospital Workers Protest Vaccine Requirement

CHARLOTTE OBSERVER – Hundreds of Charlotte-area healthcare workers and supporters protested Sunday against Atrium Health’s new coronavirus vaccination policy. The protest from Freedom Park to...

“Mask Mandates Are Stupid, And Donald Trump Won The Election”

Rep. Matt Gaetz called Dr. Anthony Fauci a “sniveling twit” and said without evidence that Democrats are using the coronavirus to create socialism in America.

“The Damn Vaccine” – Dying Dad’s Last Words

LAS VEGAS (KVVU) - A family is mourning the loss of a husband and father after he died from COVID-19. “He was only 39; our...

Pentagon Preps For Mandatory Vaccine Enforcement

WASHINGTON (AP) — Defense Secretary Lloyd Austin is vowing he "won't let grass grow under our feet" as the department begins to implement the...

Whistleblowers: Biden Admin Told Them to ‘Downplay’ COVID Outbreak in Migrant Facility

HEADLINE USA – Two whistleblowers who worked at a migrant detention facility in El Paso, Texas, said they were instructed by top Biden administration...
- Advertisement -